Table 1.
Patient characteristics.
| Characteristic | All patients (n = 40) |
|---|---|
| Median age, years (IQR) | 60 (53–66) |
| Sex, male | 23 (58, 42–71) |
| Ethnicity, n (%) | |
| Asian | 40 (100) |
| Performance status | |
| 0 | 36 (90, 77–96) |
| 1 | 3 (8, 3–20) |
| 2 | 1 (3, 0.4–13) |
| Chemotherapy regimen | |
| FOLFOX | 12 (30, 18–45) |
| CAPOX | 28 (70, 55–82) |
| Use of molecular target drug | |
| Yes | 13 (33, 20–48) |
| Colorectal resection | |
| Yes | 34 (85, 71–93) |
| Stoma | |
| Ileostomy | 5 (13, 5–26) |
| Colostomy | 3 (8, 3–20) |
| Purpose of chemotherapy | |
| Neoadjuvant treatment | 2 (5, 1–17) |
| Adjuvant treatment | 19 (48, 33–63) |
| Metastatic disease | 19 (48, 33–63) |
| Smoking history | |
| Never | 19 (48, 33–63) |
| Ex-smoker | 21 (52, 37–67) |
| Alcohol use | |
| Light/non-drinker | 30 (75, 60–86) |
| Drinker | 10 (25, 14–40) |
| History of vomiting during pregnancy | 8 (47, 26–69) |
| History of motion sickness | 5 (13, 5–26) |
IQR interquartile range.
Data are given as n (%, confidence interval) unless otherwise noted.